Dublin, June 21, 2024 (GLOBE NEWSWIRE) — The “World Market for Beauty and Personal Care” report has been added to ResearchAndMarkets.com’s offering. The beauty and...

Lexicon Seeks Approval for Sotagliflozin as an Adjunct to Insulin Therapy for Glycemic Control in People with Type 1 Diabetes and Chronic Kidney Disease Company...

Webinar will include discussion of APR-1051 in context of emerging WEE1 inhibitor landscape DOYLESTOWN, Pa., June 21, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq:...

Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second...

CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in...

CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental disease CNM-Au8 also demonstrated rescue of mitochondrial deficits in...

BEIJING, June 21, 2024 /PRNewswire/ —  A report from China Daily: China’s status as a leading industrial powerhouse in the world will become even more...

BEIJING, June 21, 2024 /PRNewswire/ — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy...

CASTRES, France, June 21, 2024 /PRNewswire/ — Pierre Fabre Laboratories has been awarded the “Prix Galien International” Prize in the “Best Product for a Rare/Orphan Disease”...

GUELPH, ON, June 21, 2024 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ), today announced that it held its Annual Meeting of...